Other findings are unchanged  [**2141-1-29**] 07:20AM BLOOD  WBC-14.6* RBC-3.10* Hgb-9.4* Hct-27.1* MCV-88 MCH-30.5 MCHC-34.8 RDW-14.1 Plt Ct-229  [**2141-1-24**] 03:39PM BLOOD  PT-14.7* PTT-42.1* INR(PT)-1.3*  [**2141-1-27**] 06:45AM BLOOD  Glucose-120* UreaN-21* Creat-1.0 Na-136 K-3.7 Cl-100 HCO3-28 AnGap-12  [**2141-1-27**] 11:47AM  URINE Color-Straw Appear-Clear Sp [**Last Name (un) **]-1.007 URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-5.0 Leuks-NEG  [**2141-1-26**] 3:25 AM  CHEST (PORTABLE AP)  COMPARISON: [**2141-1-24**].
GENERAL COMMENTS: A TEE was performed in the location listed above.
See Conclusions for post-bypass data The post-bypass study was performed while the patient was receiving vasoactive infusions (see Conclusions for listing of medications).
Following surgery he was transferred to the CVICU for invasive monitoring in stable condition.
Pt also had a pnuemomediastinum on CXR post CT DC.
3)  Report any weight gain of 2 pounds in 24 hours or 5 pounds in 1 week.
Followup Instructions: [**Hospital Ward Name 121**] 6 for wound check in 2 weeks Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] in [**1-18**] weeks Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] in [**2-19**] weeks Dr. [**Known firstname **] [**Last Name (NamePattern1) **] in 4 weeks   Completed by:[**2141-1-29**
